Exact Mass: 697.2863127999999
Exact Mass Matches: 697.2863127999999
Found 55 metabolites which its exact mass value is equals to given mass value 697.2863127999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rifamycin
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis > J04AB - Antibiotics D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives Same as: D02549
Bz-Ile-glu-gly-arg-pna
3,5,7,15,17-O-pentaacetyl-14-O-nicotinoyl-17-hydroxymyrsinol
2-O-(Indol-3-acetyl)-D-glucopyranose-trimethylsilylether
C31H59NO7Si5 (697.3137704000001)
4-O-(Indol-3-acetyl)-D-glucopyranose-trimethylsilylether
C31H59NO7Si5 (697.3137704000001)
2-O-Indol-3-acetylmyrinosit-trimethylsilylether
C31H59NO7Si5 (697.3137704000001)
1alpha,2alpha-diacetoxy-8beta-isobutanoyloxy-9alpha-benzoyloxy-13-nicotinoyloxy-4beta,6beta-dihydroxy-beta-dihydroagarofuran
1beta-acetoxy-2beta-isobutyryloxy-4alpha-hydroxy-6alpha-hydroxy-8alpha-nicotinoyloxy-9beta-benzoyloxy-11-acetoxy-dihydro-beta-agarofuran
6-O-(Indol-3-acetyl)-D-glucopyranose-trimethylsilylether
C31H59NO7Si5 (697.3137704000001)
(1R,2R)-N,N-BIS[3-OXO-2-(2,4,6-TRIMETHYLBENZOYL)BUTYLIDENE]-1,2-DIPHENYLETHYLENEDIAMINATO COBALT(II)
(1S,2S)-N,N-Bis[3-oxo-2-(2,4,6-trimethylbenzoyl)butylidene]-1,2-diphenylethylenediaminato Cobalt(II)
Betalutin
D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies
N-(2-aminophenyl)-N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide
C36H45Cl2N5O5 (697.2797579999999)
N-(2-aminophenyl)-N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]heptanediamide
C36H45Cl2N5O5 (697.2797579999999)
N-(2-aminophenyl)-N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]heptanediamide
C36H45Cl2N5O5 (697.2797579999999)
N-(2-aminophenyl)-N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide
C36H45Cl2N5O5 (697.2797579999999)
N-(2-aminophenyl)-N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide
C36H45Cl2N5O5 (697.2797579999999)
N-(2-aminophenyl)-N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide
C36H45Cl2N5O5 (697.2797579999999)
QWF Peptide
C38H43N5O8 (697.3111478000001)
QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1]. QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1].
(1r,2r,3r,4s,5s,7r,8s,9r,10r,11s,14r,15r)-2,4,7,14,15-pentakis(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-8-yl pyridine-3-carboxylate
[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4as,5ar)-4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2z)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4as,5ar)-4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
(2s,3r,4r,5r,6r)-2,4,5-tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}oxan-3-yl 2-[1-(trimethylsilyl)indol-3-yl]acetate
C31H59NO7Si5 (697.3137704000001)
2,4,5-tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}oxan-3-yl 2-[1-(trimethylsilyl)indol-3-yl]acetate
C31H59NO7Si5 (697.3137704000001)
[1-(trimethylsilyl)indol-3-yl]methyl 2-{3,4,5,6-tetrakis[(trimethylsilyl)oxy]oxan-2-yl}acetate
C31H59NO7Si5 (697.3137704000001)
(7e,13e,15e,17e,19e)-21-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-1,3,5,6,25-pentahydroxy-11,12-dimethyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid
C34H51NO14 (697.3309386000001)
(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1(29),2,4,9,19,21,23,25,27-nonaen-13-yl acetate
{6-[(4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methyl 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
[(1s,2s,4s,5r,6s,7s,8s,9s,12r)-4,5-bis(acetyloxy)-7-(benzoyloxy)-2,12-dihydroxy-2,10,10-trimethyl-8-[(2-methylpropanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl pyridine-3-carboxylate
[1-(trimethylsilyl)indol-3-yl]methyl (2s,3r,4s,5r,6s)-4,5,6-tris[(trimethylsilyl)oxy]-2-{[(trimethylsilyl)oxy]methyl}oxane-3-carboxylate
C31H59NO7Si5 (697.3137704000001)
2-[(4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
[4,5-bis(acetyloxy)-7-(benzoyloxy)-2,12-dihydroxy-2,10,10-trimethyl-8-[(2-methylpropanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl pyridine-3-carboxylate
(2s,3r,4s,5s,6r)-2-{[(3s,4r,4as,5ar)-4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
(1r,3s,5r,6r,7z,11r,12s,13z,15z,17z,19z,21r,23s,24r,25s)-21-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,5,6,25-pentahydroxy-11,12-dimethyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid
C34H51NO14 (697.3309386000001)
[1-(trimethylsilyl)indol-3-yl]methyl 4,5,6-tris[(trimethylsilyl)oxy]-2-{[(trimethylsilyl)oxy]methyl}oxane-3-carboxylate
C31H59NO7Si5 (697.3137704000001)
(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1(29),2,4,9,19,21,23,25,27-nonaen-13-yl acetate
[1-(trimethylsilyl)indol-3-yl]methyl 2-[(2r,3r,4s,5r,6r)-3,4,5,6-tetrakis[(trimethylsilyl)oxy]oxan-2-yl]acetate
C31H59NO7Si5 (697.3137704000001)